Orexo AB ADR

(ORXOY)

By |

Profile

Orexo AB develops pharmaceuticals and digital therapies addressing unmet needs within the space of substance use disorders and mental health. The products are commercialized by Orexo in the USA or via partners worldwide. The main market is the American market for buprenorphine/naloxone products, where the company commercializes its product Zubsolv for treatment of opioid use disorder. The head office, where research and development is also performed, is situated in Uppsala, Sweden.

Contact Information

Website: www.orexo.com
Email: beata.augenblick@orexo.com
Main Phone: +46 187808800
Address: Virdings alle 32 A
Address 2: P.O. Box 303
City / Town: Uppsala
Country: SE
Postal Code: 75105

Issuer Information

Exchange: OTCQX
Employees: 136

Equities News

Profile

Orexo AB develops pharmaceuticals and digital therapies addressing unmet needs within the space of substance use disorders and mental health. The products are commercialized by Orexo in the USA or via partners worldwide. The main market is the American market for buprenorphine/naloxone products, where the company commercializes its product Zubsolv for treatment of opioid use disorder. The head office, where research and development is also performed, is situated in Uppsala, Sweden.

Contact Information

Website: www.orexo.com
Email: beata.augenblick@orexo.com
Main Phone: +46 187808800
Address: Virdings alle 32 A
Address 2: P.O. Box 303
City / Town: Uppsala
Country: SE
Postal Code: 75105

Issuer Information

Exchange: OTCQX
Employees: 136

Equities News

$ 5.45 $ 0. (0.00%)
Last Price 5.45 Change $ 0. Change % 0.00 Tick N/A
Bid 5.00 Bid Size 100.00 Ask 5.55 Ask Size 100.00
Open N/A High N/A Low N/A Prev Close 5.45
Last Trade Volume 0 52 Wk Hi 9.00 52 Wk Low 5.00
Market Cap 186.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 34,210,639.00 EPS (TTM) 0.57 PE Ratio 697.90 Exchange OTCQX